A $9B valuation for Neuralink prices in a future where brain implants are routine — but today's devices help a few dozen people in trials. Our read on the gap between capital and clinical reality. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
165 launches and a 32-flight booster put SpaceX years ahead, but Blue Origin's New Glenn reuse and Rocket Lab's Neutron are finally real. Our read on how durable the lead is. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
eVTOL leaders are pre-revenue and burning cash toward certification. Joby and Archer have raised billions and look funded; many European rivals already went bankrupt. Our read on who has the runway. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
Waymo leads on paid driverless rides and miles; Tesla is betting on a camera-only, mass-market path; Cruise exited in 2024. We weigh the very different strategies. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
A $39B valuation for Figure and billions across the field price in success that hardware and autonomy haven't yet delivered. Our read on whether capital is ahead of capability. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
Big tech power deals and listed names (NuScale, Oklo) have lifted SMR sentiment, but Western first-of-a-kind units don't reach the grid until ~2030. We weigh the gap between order books and operating reactors. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
Cumulative private funding has crossed ~$9.8B across 53 companies (FIA 2025). We look at what the money is — and isn't — telling investors about timelines. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
Records are falling fast — gain 4 at NIF, 1,000 s-plus plasmas in China and France — but engineering breakeven and a grid-connected plant are still distinct, harder steps. Our read on the gap. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
Logical-qubit records are climbing fast, but breaking RSA-2048 needs thousands of logical (millions of physical) qubits with low error rates held for hours. Our read: real, but not imminent. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
TSMC holds ~two-thirds of the market and the yield lead; Intel is betting its comeback on 18A; Samsung trails on yield. Our read on a race where one player's dominance keeps compounding. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
Most station contenders are private — Vast is self-funded, Axiom and Blue Origin unlisted — leaving Voyager Technologies (NYSE: VOYG) as the main public play. Our read on a capital-hungry race with one listed runner. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.
US private AI investment hit $109B in 2024 — then 2025's efficiency shock (DeepSeek) made the bubble question sharper, not simpler. Our read on whether capital is ahead of capability. (Our opinion, not investment advice.)
Our read — labelled opinion, not investment advice.